Cite
HARVARD Citation
Franken, M. et al. (n.d.). 2119 Capecitabine and bevacizumab (CB) maintenance treatment in metastatic colorectal cancer (mCRC): A cost-effectiveness analysis. European journal of cancer. pp. S370-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Franken, M. et al. (n.d.). 2119 Capecitabine and bevacizumab (CB) maintenance treatment in metastatic colorectal cancer (mCRC): A cost-effectiveness analysis. European journal of cancer. pp. S370-. [Online].